Skip to main content
GeneOne Life Science, Inc. logo

GeneOne Life Science, Inc. — Investor Relations & Filings

Ticker · 011000 ISIN · KR7011000007 KO Professional, scientific and technical activities
Filings indexed 480 across all filing types
Latest filing 2026-05-07 Regulatory Filings
Country KR South Korea
Listing KO 011000

About GeneOne Life Science, Inc.

https://www.genels.com/en/

GeneOne Life Science, Inc. is a biopharmaceutical research and development company specializing in nucleic acid-based biomedicines. The company's core focus is on developing DNA and mRNA vaccines, particularly for emerging infectious diseases, leveraging its rapid development platforms. In therapeutics, GeneOne utilizes a proprietary DNA plasmid delivery technology to enable the expression of recombinant proteins and plasmid-encoded monoclonal antibodies (Plas-mAbs®). This non-viral vector approach is designed to offer a safer and more cost-effective alternative to traditional gene therapies and cell-line derived monoclonal antibody treatments for conditions such as cancers and autoimmune disorders. The company also develops immunomodulatory small molecule drugs. Through its subsidiary, GeneOne possesses cGMP-grade manufacturing capabilities for DNA plasmids, supporting its internal pipeline and contract manufacturing services.

Recent filings

Filing Released Lang Actions
유상증자또는주식관련사채등의발행결과(자율공시)
Regulatory Filings
2026-05-07 Korean
[기재정정]타법인주식및출자증권취득결정
Regulatory Filings
2026-04-30 Korean
[기재정정]유상증자결정(종속회사의주요경영사항)
Regulatory Filings
2026-04-30 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 95% confidence The document is titled “의결권대리행사권유 참고서류” (proxy solicitation reference materials) and details materials provided to shareholders to solicit proxy votes ahead of a shareholders’ meeting, including agenda items, proxy agents, delegation methods, and agenda explanations. This matches the definition for Proxy Solicitation & Information Statement (PSI).
2026-04-29 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a detailed shareholders’ meeting convocation notice (“주주총회소집공고”) including agenda items, director candidate biographies, capital reduction proposal, outside director activity and remuneration details, related‐party transactions, and business overviews. It is not a voting results announcement or an earnings/annual report but rather the full information package sent to shareholders to solicit their votes at the Extraordinary General Meeting. This corresponds to a Proxy Solicitation & Information Statement (PSI).
2026-04-29 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 93% confidence The document is titled “의결권대리행사권유참고서류” and details the solicitation of proxy voting for a shareholders’ meeting (agenda items, proxy agents, voting methods, meeting date changes, capital reduction, director appointments, etc.). This matches the definition of a Proxy Solicitation & Information Statement (PSI).
2026-04-29 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.